Donanemab for Treatment of Alzheimer Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
Donanemab for Treatment of Alzheimer Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1 year ago
neurologylive.com
Understanding Donanemab: The Alzheimer's Drug That's Making Waves
Understanding Donanemab: The Alzheimer's Drug That's Making Waves
May 25, 2024
usc.edu
Is the Alzheimer's drug Donanemab really a turning point for treatment?
7:51
Is the Alzheimer's drug Donanemab really a turning point for treatment?
Jul 25, 2023
ABC NewsNorman Swan
There’s more mixed news on another Alzheimer’s disease drug. Donanemab is the second drug this year to be approved by the MHRA as a safe and effective treatment for early Alzheimer’s disease. This is another milestone. However, draft guidance from NICE which considers both the benefits and costs of the drugs, did not recommend donanemab be provided on the NHS. We know this is disappointing, but research will beat dementia. There are around 20 disease modifying treatments in late-stage trials for
2:22
There’s more mixed news on another Alzheimer’s disease drug. Donanemab is the second drug this year to be approved by the MHRA as a safe and effective treatment for early Alzheimer’s disease. This is another milestone. However, draft guidance from NICE which considers both the benefits and costs of the drugs, did not recommend donanemab be provided on the NHS. We know this is disappointing, but research will beat dementia. There are around 20 disease modifying treatments in late-stage trials for
2.4K viewsOct 23, 2024
FacebookAlzheimer's Society
Drug Donanemab found to slow Alzheimer's
3:02
Drug Donanemab found to slow Alzheimer's
Jul 18, 2023
wionews.com
Donanemab approved in Australia for treatment of Alzheimer's disease
4:26
Donanemab approved in Australia for treatment of Alzheimer's disease
11 months ago
ABC Newsthe Specialist Reporting Team's Paige Cockburn
Today an FDA advisory panel is meeting to discuss donanemab for the treatment of Alzheimer disease. JAMA published the results of the TRAILBLAZER-ALZ 2 trial which found that donanemab treatment significantly slowed clinical progression at 76 weeks. Read the study: https://ja.ma/3X7Q2Rs | JAMA
0:59
Today an FDA advisory panel is meeting to discuss donanemab for the treatment of Alzheimer disease. JAMA published the results of the TRAILBLAZER-ALZ 2 trial which found that donanemab treatment significantly slowed clinical progression at 76 weeks. Read the study: https://ja.ma/3X7Q2Rs | JAMA
513 viewsJun 10, 2024
FacebookJAMA
3:48
Donanemab For Alzheimer’s: Mechanism of Action & Key Clinical Study Results Explained│ Pharmacology
2.5K viewsJul 2, 2024
YouTubePharmacology Insights
FDA approves Donanemab, new Eli Lilly treatment for early Alzheimer’s disease
Jul 3, 2024
wxyz.com
2:03
Growing hope over a new Alzheimer's drug, but there are side effects
Jul 2, 2024
CBC
Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use
9 months ago
marketscreener.com
6:55
Guidance on Safe Use of Donanemab for Alzheimer Disease in Clinical Settings
368 viewsNov 22, 2024
YouTubeNeurologyLive
FDA advisers strongly back new Alzheimer’s drug, despite risks and limitations
Jun 10, 2024
npr.org
3:42
Alzheimer's Disease: How does it work? How can Donanemab help?
3.2K viewsMay 8, 2023
YouTubeBioDigital, Inc.
33:50
A Deep Dive Into the Investigational Alzheimer’s Drug Donanemab | LiveTalk | Being Patient
2.9K viewsJul 20, 2021
YouTubeBeing Patient
8:21
Lecanemab vs. Donanemab: Expert Breakdown of Alzheimer’s Treatments | Dr. Khushboo Verma
5.6K viewsDec 21, 2024
YouTubeThe Dementia Doctor
5:37
Understanding Kisunla (Donanemab) and AD Treatment Options
3.2K viewsOct 17, 2024
YouTubeAlzheimer’s Therapeutic Research Institute (AT…
2:14
Promising Alzheimer's drug Donanemab offers hope for millions, awaits FDA approval
Jul 17, 2023
wjla.com
1:03
How Donanemab and Lecanemab treat Alzheimer's disease
1.9K viewsSep 25, 2024
YouTubeUCLA Neurology
2:41
Alzheimer’s drug, donanemab, to be FDA approved by end of 2023
Jul 18, 2023
rochesterfirst.com
17:10
Episode 146: Overviewing Donanemab’s New Dosing Regimen: Lowering ARIA Risk in Alzheimer Care
167 views9 months ago
YouTubeNeurologyLive
1:23
Reshaping the Fight Against Alzheimer's: The Donanemab Revolution
1.2K viewsMay 27, 2023
YouTubeThe Brain Docs
1:30:12
A New Era: Understanding Lecanemab, Donameb, and Emerging Therapies for Alzheimer's Disease
1.5K viewsNov 9, 2023
YouTubeUMNCHAI
New treatment gives hope to patients with Alzheimer's disease
4 weeks ago
dailytelegraphSarah Booth
1:40
Donanemab Shows Robust Amyloid Lowering in Alzheimer Disease
225 views3 weeks ago
YouTubePsychiatric Times
5:29
Kisunla” is the brand name for donanemab-azbt, a monoclonal antibody for Alzheimer’s disease! Coming for ya! Again. Apparently, 2/3 of us have got Alzheimer’s and we don’t even know! | Kate Shemirani
17.1K views7 months ago
FacebookKate Shemirani
New treatment gives hope to patients with Alzheimer’s disease
3 months ago
theaustralian.com.au
2:46
New treatment to slow progression of early Alzheimer's approved by FDA
2.9K viewsJul 3, 2024
YouTubeCBS News
0:11
The Healthy Brain and Memory Centre on Instagram: "Two breakthrough Alzheimer’s therapies. One shared goal: slowing disease progression. Both Lecanemab and Donanemab are monoclonal antibodies that remove amyloid-β from the brain. Lecanemab — Clears the “toxic seeds” early: Designed to bind soluble amyloid protofibrils (the smaller, mobile, most toxic forms). Think: stopping the sparks before they become a fire. Donanemab — Clears established plaque: Targets N3pG-modified plaque, meaning it binds
263 views5 months ago
Instagramthehealthybrainandmemorycentre
5:23
New Alzheimer’s Drugs Explained: Lecanemab & Donanemab for Families (Risks, Benefits, Costs)
300 views5 months ago
YouTubeDr. Luis E Zayas, MD PT
See more